Albany Molecular Research (AMRI)
|
5.85
+0.04 (+0.69%)
|
|
|
|
AMRI additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
AMRI Profile
•
Exchange
NASDAQ
•
Executives
Dr. Thomas E. D'Ambra Ph.D.
Co-Founder
Chairman Chief Exec. Officer and Pres
Dr. Bruce J. Sargent Ph.D.
Sr. VP of Drug Discovery
Ms. Lori M. Henderson Esq.
VP
Gen. Counsel and Sec.
Dr. Steven R. Hagen Ph.D.
VP of Pharmaceutical Devel. & Manufacturing
Mr. Michael Nolan
Chief Financial Officer
VP and Treasurer
Co-Founder
Chairman Chief Exec. Officer and Pres
Dr. Bruce J. Sargent Ph.D.
Sr. VP of Drug Discovery
Ms. Lori M. Henderson Esq.
VP
Gen. Counsel and Sec.
Dr. Steven R. Hagen Ph.D.
VP of Pharmaceutical Devel. & Manufacturing
Mr. Michael Nolan
Chief Financial Officer
VP and Treasurer
•
Employee Count
1,389
Special Offers
Competitors
AMRI earnings
Date
Actual
Expected
Prev Yr Qtr
11/6/2012
0.00
-0.02
-0.19
8/1/2012
0.06
0.02
-0.02
5/9/2012
0.02
0.05
-0.02
